Potential impact of newborn screening for cystic fibrosis on child survival: A systematic review and analysis

被引:81
作者
Grosse, Scott D.
Rosenfeld, Margaret
Devine, Owen J.
Lai, HuiChuan J.
Farrell, Philip M.
机构
[1] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA 30333 USA
[2] Childrens Hosp & Reg Med Ctr, Div Pulm Med, Seattle, WA USA
[3] Univ Wisconsin, Coll Agr & Life Sci, Dept Nutr Sci, Madison, WI 53706 USA
[4] Univ Wisconsin, Sch Med, Dept Biostat & Med Informat, Madison, WI 53706 USA
[5] Univ Wisconsin, Sch Med, Dept Pediat, Madison, WI 53706 USA
关键词
D O I
10.1016/j.jpeds.2006.04.059
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
Objective To estimate the population impact of child mortality as a result of cystic fibrosis (CF) potentially preventable by newborn screening. Study design A systematic literature review of mortality in children with classic CF without meconium ileus (MI) in screened and unscreened cohorts was extended by contacting investigators for unpublished data. In addition, survival in US states with and without newborn screening (NBS) programs for CF was compared using data from the Cystic Fibrosis Foundation Patient Registry (CFFPR). Results Among non-US studies, CF-related mortality risk to approximately 10 years of age was lower by 5 to 10 per 100 in screened cohorts. Unpublished US data from a trial of NBS for CF indicate no CF-related deaths to 10 years of age in either cohort. CFFPR data suggest improved survival among children with CF born in US states with NBS, with a CF-related mortality difference to 10 years of age between the screened and unscreened groups between 1.5 and 2 per 100 children with CF without MI. Conclusion In addition to improving nutritional outcomes, newborn screening for CF may result in improved child survival. The absolute differential in mortality risk, although modest in size, appears comparable to NBS for certain other genetic disorders.
引用
收藏
页码:362 / 366
页数:5
相关论文
共 37 条
[1]  
*AM COLL MED GEN, 2005, NEWB SCREEN UN SCREE
[2]  
[Anonymous], 1997, MMWR Recomm Rep, V46, P1
[3]   Epidemiology and survival analysis of cystic fibrosis in an area of intense neonatal screening over 30 years [J].
Assael, BM ;
Castellani, C ;
Ocampo, MB ;
Iansa, P ;
Callegaro, A ;
Valsecchi, MG .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (05) :397-401
[4]   Stature as a prognostic factor in cystic fibrosis survival [J].
Beker, LT ;
Russek-Cohen, E ;
Fink, RJ .
JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION, 2001, 101 (04) :438-442
[5]   Newborn screening for cystic fibrosis: An opportunity to improve care and outcomes [J].
Campbell, PW ;
White, TB .
JOURNAL OF PEDIATRICS, 2005, 147 (03) :S2-S5
[6]  
Castellani Carlo, 2003, Paediatr Respir Rev, V4, P278, DOI 10.1016/S1526-0542(03)00085-X
[7]   NEONATAL SCREENING FOR CYSTIC-FIBROSIS IN WALES AND THE WEST MIDLANDS - CLINICAL-ASSESSMENT AFTER 5 YEARS OF SCREENING [J].
CHATFIELD, S ;
OWEN, G ;
RYLEY, HC ;
WILLIAMS, J ;
ALFAHAM, M ;
GOODCHILD, MC ;
WELLER, P .
ARCHIVES OF DISEASE IN CHILDHOOD-FETAL AND NEONATAL EDITION, 1991, 66 (01) :29-33
[8]  
*CYST FIBR FDN, 2004, CYST FIBR FDN PAT RE
[9]   Review of outcomes of neonatal screening for cystic fibrosis versus non-screening in Europe [J].
Dankert-Roelse, JE ;
Mérelle, ME .
JOURNAL OF PEDIATRICS, 2005, 147 (03) :S15-S20
[10]   Cystic fibrosis-related deaths in infancy and the effect of newborn screening [J].
Doull, IJM ;
Ryley, HC ;
Weller, P ;
Goodchild, MC .
PEDIATRIC PULMONOLOGY, 2001, 31 (05) :363-366